Patents Assigned to Jenius Pharma, LLC
  • Treatments for diseases and disorders that involve oxidative stress
    Patent number: 12454549
    Abstract: Peptide compounds and their use in treating diseases and disorders that cause, are caused by, or are characterized by cellular oxidative stress.
    Type: Grant
    Filed: June 6, 2023
    Date of Patent: October 28, 2025
    Assignee: Jenius Pharma, LLC
    Inventors: Hampar L Karageozian, Vicken H Karageozian, John Y Park